We then measured plasma BMP9 in the cohort of 40 IPAH subjects obtained from the PAH biobank, finding plasma BMP9 remained significantly lower in PoPH subjects when compared to those with IPAH (Table 3, Fig. 3c). This evidence concerns the gene GDF2 and Pulmonary arterial hypertension associated with portal hypertension.